Artículos relacionados

Prevalence of neurological manifestations in COVID-19 and their association with mortality
Introduction Articles published in the literature report neurological manifestations or “complications” of SARS-CoV-2 infection and conclude that the different neurological manifestations are relatively similar, but with different frequencies. This study aimed to determine the frequency […]

Avelumab to treat Merkel cell carcinoma: real-life experience in a dedicated oncology center
The arrival of immunotherapy has revolutioned the management of patients with metastatic Merkel cell carcinoma (MCC). We conducted an observational, retrospective study of 14 cases treated with avelumab. The response rate was 57%: complete response […]
Acute stroke in COVID-19 patients: A first year experience in a Colombian hospital
Background COVID-19 may be a new risk factor for stroke. Stroke in COVID-19 varies from 1.1 to 8.1%. Various pathophysiological pathways predispose SARS-CoV-2 infected patients to stroke. Aim To describe COVID-19 patients with acute stroke […]